Evaluation of digital PCR for detecting low-level EGFR mutations in advanced lung adenocarcinoma patients: a cross-platform comparison study

Emerging evidence has indicated that circulating tumor DNA (ctDNA) from plasma could be used to analyze EGFR mutation status for NSCLC patients; however, due to the low level of ctDNA in plasma, highly sensitive approaches are required to detect low frequency mutations. In addition, the cutoff for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Jincui, Zang, Wanchun, Liu, Bing, Li, Lei, Huang, Lixia, Li, Shaoli, Rao, Guanhua, Yu, Yang, Zhou, Yanbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620214/
https://www.ncbi.nlm.nih.gov/pubmed/28978074
http://dx.doi.org/10.18632/oncotarget.18866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620214/
https://www.ncbi.nlm.nih.gov/pubmed/28978074
http://dx.doi.org/10.18632/oncotarget.18866

Ejemplares similares